angiotensin ii has been researched along with glycosides in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grotemeyer, J; Schlag, EW | 1 |
| Huber, G; Jaques, R; Meier, R; Neipp, L; Rossi, A; Schär, B | 1 |
| Huang, BS; Leenen, FH; Yuan, B | 1 |
| Liu, SJ; Liu, WZ; Liu, Y; Tan, YZ; Yang, ZC; Zhang, X | 1 |
| Chen, SH; Gao, JL; Lei, J; Li, B; Lv, GY; Yu, JJ; Zhan, RJ; Zhang, YP; Zhang, ZR | 1 |
| Cao, W; Cheng, J; Guo, X; Hu, N; Hu, P; Wang, X; Wang, Y; Yuan, Y | 1 |
| Cai, W; Qiu, L; Sun, H; Zhang, Q; Zhou, Y; Zhou, Z; Zhu, X | 1 |
| Chung, MH; Hong, EY; Hong, GU; Kang, H; Kim, SC; Kim, TY; Kim, YH; Kwon, YI; Lee, JY; Park, JY; Ro, JY | 1 |
| Abbas, M; Auger, C; Belcastro, E; Hasan, H; Jesel, L; Marchandot, B; Matsushita, K; Morel, O; Ohlmann, P; Park, SH; Schini-Kerth, VB; Toti, F | 1 |
| Hao, RJ; Lu, YW; Wei, YY; Yu, GR | 1 |
10 other study(ies) available for angiotensin ii and glycosides
| Article | Year |
|---|---|
Laser-desorption/Laser-ionization mass spectrometry of biomolecules.
Topics: Angiotensin II; Gas Chromatography-Mass Spectrometry; Glycosides; Insulin; Lasers; Mass Spectrometry; Peptides; Steroids | 1988 |
[A chemically and pharmacologically novel antagonist of physiopathologically important amines, kinins and kinin-forming factors].
Topics: Acetylcholine; Anaphylaxis; Angiotensin II; Animals; Antimetabolites; Arachidonic Acids; Autacoids; Bradykinin; Chemistry, Organic; Drug Antagonism; Epinephrine; Glucose; Glycosides; Histamine; In Vitro Techniques; Inflammation; Kinins; Mice; Muscle, Smooth; Organic Chemistry Phenomena; Peroxides; Rabbits; Rats; Serotonin; Trypsin; Vasopressins; Venoms | 1967 |
Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Brain; Cardenolides; Glycosides; Heart; Hemodynamics; Hyperemia; Hypertension; In Vitro Techniques; Male; Myocardial Infarction; Rats; Rats, Wistar | 1999 |
[Effect of TGRJ on blood press, NO and Ang II in renal hypertensive rats].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Female; Glycosides; Hypertension, Renal; Kidney; Male; Myocytes, Smooth Muscle; Nitric Oxide; Ranunculus; Rats; Rats, Sprague-Dawley | 2012 |
Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Drug Therapy, Combination; Endothelins; Epoprostenol; Glycosides; Hypertension; Luteolin; Male; Nitric Oxide; Rats; Rats, Inbred SHR; Renin; Thromboxane B2 | 2013 |
Effects of Tilianin on Proliferation, Migration and TGF-β/Smad Signaling in Rat Vascular Smooth Muscle Cells Induced with Angiotensin II.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Flavonoids; Glycosides; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1 | 2017 |
Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Glycosides; Hypertension; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Ventricular Remodeling | 2018 |
Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells.
Topics: Angiotensin II; Animals; Biological Products; Chemokine CCL2; Gene Expression Regulation; Glucosides; Glycosides; Humans; Hydrogen Peroxide; Lignans; Norisoprenoids; Oxidation-Reduction; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2019 |
Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins.
Topics: Aged; Aged, 80 and over; Angiotensin II; Animals; Benzhydryl Compounds; Cell-Derived Microparticles; Cells, Cultured; Cellular Senescence; Endothelial Cells; Female; Glucosides; Glycosides; Humans; Male; Middle Aged; Oxidative Stress; Rats, Wistar; Signal Transduction; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sus scrofa; Up-Regulation | 2021 |
The protective effect of harpagoside on angiotensin II (Ang II)-induced blood-brain barrier leakage in vitro.
Topics: Angiotensin II; Blood-Brain Barrier; Glycosides; Pyrans; Reactive Oxygen Species | 2021 |